S-2474 | 158089-95-3 | COX-2 inhibitor

MedKoo Cat#: 526958 | Name: S-2474

Description:

WARNING: This product is for research use only, not for human or veterinary use.

S-2474 is a COX-2 inhibitor potentially for the treatment of rheumatoid arthritis (RA). S-2474 rescues cortical neurons from human group IIA secretory phospholipase A(2)-induced apoptosis. S-2474 significantly prevented neurons from Abeta(25 - 35)- and Abeta(1 - 40)-induced cell death. S-2474 ameliorated Abeta-induced apoptotic features such as the condensation of chromatin and the fragmentation of DNA completely. S-2474 exhibits protective effects against neurotoxicity of Abeta. S-2474 may possess therapeutic potential for AD via ameliorating degeneration in neurons as well as suppressing chronic inflammation in non-neuronal cells.

Chemical Structure

S-2474

CAS#158089-95-3

Theoretical Analysis

MedKoo Cat#: 526958

Name: S-2474

CAS#: 158089-95-3

Chemical Formula: C20H31NO3S

Exact Mass: 365.2025

Molecular Weight: 365.53

Elemental Analysis: C, 65.72; H, 8.55; N, 3.83; O, 13.13; S, 8.77

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.

Bulk Inquiry

Related CAS #

No Data

Synonym

S-2474; S 2474; S2474.

IUPAC/Chemical Name

(E)-5-(3,5-di-tert-butyl-4-hydroxybenzylidene)-2-ethylisothiazolidine 1,1-dioxide

InChi Key

HFWZBWTWCKQUCB-RVDMUPIBSA-N

InChi Code

InChI=1S/C20H31NO3S/c1-8-21-10-9-15(25(21,23)24)11-14-12-16(19(2,3)4)18(22)17(13-14)20(5,6)7/h11-13,22H,8-10H2,1-7H3/b15-11+

SMILES Code

CC(C)(C)C1=C(O)C(C(C)(C)C)=CC(/C=C2CCN(CC)S\2(=O)=O)=C1

Appearance

Solid powder

Purity

>98% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility

Soluble in DMSO

Shelf Life

>2 years if stored properly

Drug Formulation

This drug may be formulated in DMSO

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.9001

More Info

Instruction

View handling instruction

Preparing Stock Solutions

The following data is based on the product molecular weight 365.53 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

1: Yagami T, Ueda K, Hata S, Kuroda T, Itoh N, Sakaguchi G, Okamura N, Sakaeda T, Fujimoto M. S-2474, a novel nonsteroidal anti-inflammatory drug, rescues cortical neurons from human group IIA secretory phospholipase A(2)-induced apoptosis. Neuropharmacology. 2005 Aug;49(2):174-84. PubMed PMID: 15996566. 2: Inagaki M. [Studies on the new antiarthritic drug candidate S-2474]. Yakugaku Zasshi. 2003 May;123(5):323-30. Review. Japanese. PubMed PMID: 12772588. 3: Inagaki M, Jyoyama H, Ono T, Yamada K, Kobayashi M, Baba T, Touchi A, Iwatani K, Ohkawa T, Matsumoto S, Tsuri T. Synthesis and activities of oxidative metabolites of the anti-arthritic drug candidate S-2474. Bioorg Med Chem. 2003 May 29;11(11):2415-9. PubMed PMID: 12735987. 4: Inagaki M, Matsumoto S, Tsuri T. Short synthesis of tert-butyl-hydroxylated 3,5-di-tert-butyl-4-hydroxybenzaldehyde: Synthesis of tert-butyl-hydroxylated S-2474. J Org Chem. 2003 Feb 7;68(3):1128-31. PubMed PMID: 12558443. 5: Kato M, Nishida S, Kitasato H, Sakata N, Kawai S. Cyclooxygenase-1 and cyclooxygenase-2 selectivity of non-steroidal anti-inflammatory drugs: investigation using human peripheral monocytes. J Pharm Pharmacol. 2001 Dec;53(12):1679-85. PubMed PMID: 11804398. 6: Inagaki M, Haga N, Kobayashi M, Ohta N, Kamata S, Tsuri T. Highly E-selective and effective synthesis of antiarthritic drug candidate S-2474 using quinone methide derivatives. J Org Chem. 2002 Jan 11;67(1):125-8. PubMed PMID: 11777449. 7: Yagami T, Ueda K, Asakura K, Sakaeda T, Kuroda T, Hata S, Kambayashi Y, Fujimoto M. Effects of S-2474, a novel nonsteroidal anti-inflammatory drug, on amyloid beta protein-induced neuronal cell death. Br J Pharmacol. 2001 Oct;134(3):673-81. PubMed PMID: 11588123; PubMed Central PMCID: PMC1572969. 8: Inagaki M, Tsuri T, Jyoyama H, Ono T, Yamada K, Kobayashi M, Hori Y, Arimura A, Yasui K, Ohno K, Kakudo S, Koizumi K, Suzuki R, Kawai S, Kato M, Matsumoto S. Novel antiarthritic agents with 1,2-isothiazolidine-1,1-dioxide (gamma-sultam) skeleton: cytokine suppressive dual inhibitors of cyclooxygenase-2 and 5-lipoxygenase. J Med Chem. 2000 May 18;43(10):2040-8. PubMed PMID: 10821716.